Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Clinical Study to Establish the Safety and Effectiveness of the Use of BioTraceIO Lite for Assessment of Tissue Damage Following Liver Tissue Ablation Procedures

NCT04970212 is registered in ClinicalTrials.gov with Techsomed Medical Technologies LTD as lead sponsor.

NCT NCT04970212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04970212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Clinical Study to Establish the Safety and Effectiveness of the Use of BioTraceIO Lite for Assessment of Tissue Damage Following Liver Tissue Ablation Procedures
Lead sponsor
Techsomed Medical Technologies LTD
Phase
Observational
Overall status
Completed
Start date
September 24, 2021
Completion date
October 8, 2022
Enrollment
65 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular, metastatic liver cancer